According to a recent LinkedIn post from Acclaro Medical, the company is promoting a live webinar centered on its AuraLux laser platform, featuring Lavi Aesthetics and its owner, Lavi Londonson, BSN, RN. The post indicates the session will focus on real-world use cases, patient stories, and how the 2910 nm Cold Fiber Laser supports what the firm brands as Total Skin Health.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn content also suggests that AuraLux is being positioned as a tool for aesthetic practices to expand beyond injectable treatments, with expert commentary from Max Maxwell and Londonson. For investors, this emphasis on education, practitioner testimonials, and clinical storytelling may signal a demand-generation strategy aimed at accelerating adoption of Acclaro Medical’s newest platform in the competitive aesthetics device market.
The focus on safety, comfort, and practice expansion could point to efforts to differentiate AuraLux from other energy-based devices and to drive recurring revenue through increased procedural usage. If the webinar succeeds in converting attendees into customers or expanding utilization among existing users, it could support revenue growth and strengthen Acclaro Medical’s positioning in the professional aesthetics segment over the medium term.